Gliabetes Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Pioglitazone

Indications/Uses

Combination therapy w/ sulphonylurea or metformin in patients w/ type 2 DM (NIDDM) when monotherapy is inadequate.

Dosage/Direction for Use

Adult Combination therapy w/ metformin & sulphonylurea Initially 15-30 mg/day.

Administration

May be taken with or without food.

Contraindications

Hepatic dysfunction, heart failure (NYHA stages III or IV), combination w/ insulin, type 1 DM or ketoacidosis.

Special Precautions

Fluid retention, cardiac failure. Pregnancy & lactation. Childn & adolescent <18 yr.

Adverse Reactions

Anemia, wt gain, headache, arthralgia; increased appetite & LDH level; hypoglycaemia, glycosuria, visual disturbances.

View ADR Reporting Link

Drug Interactions

Cytochrome P-450 3A4 inhibitor or inducer.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BG03 - pioglitazone ; Belongs to the class of thiazolidinediones. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Gliabetes tab 30 mg

Packing/Price

3 × 10's (Rp270,000/boks)

Gliabetes